Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Prostate cancer: diagnosis and management

NICE guideline
Reference number: NG131
Published: 09 May 2019
Last updated: 15 December 2021

History

Guidance published

Consultation comments and responses (PDF 1.03 MB)

Published:

15 December 2021
Committee member list (PDF 120 KB)

Published:

15 December 2021
Equality impact assessment 4 (PDF 147 KB)

Published:

15 December 2021

Draft guidance consultation

Draft guidance consultation
Evidence review NG131 (PDF 1.82 MB)

Published:

21 October 2021
Evidence review NG12 (PDF 3.53 MB)

Published:

21 October 2021
Equality impact assessment 3 (PDF 172 KB)

Published:

21 October 2021
Committee member list (PDF 120 KB)

Published:

21 October 2021
Comments form (MSWord 40 KB)

Published:

21 October 2021
Draft guideline NG131 (PDF 421 KB)

Published:

21 October 2021
Draft guideline NG12 (PDF 209 KB)

Published:

21 October 2021

Stakeholder list updated

Stakeholder list (PDF 220 KB)

Published:

14 December 2021

Committee list updated

Committee member list (PDF 120 KB)

Published:

06 October 2021

Declaration of interests

Register of interests (PDF 398 KB)

Published:

14 December 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 433 KB)

Published:

08 September 2021
Minutes 2 (PDF 182 KB)

Published:

15 September 2021
Minutes Post-consultation (PDF 180 KB)

Published:

15 November 2021

Scope published

Final scope (PDF 252 KB)

Published:

18 August 2021

Update on 15 December 2021

Guidance published
Equality impact assessment (PDF 147 KB)

Published:

15 December 2021
Committee member list (PDF 120 KB)

Published:

15 December 2021
Consultation comments and responses (PDF 1.03 MB)

Published:

15 December 2021
Draft guidance consultation
Draft guidance consultation
Evidence review NG131 (PDF 1.82 MB)

Published:

21 October 2021
Evidence review NG12 (PDF 3.53 MB)

Published:

21 October 2021
Equality impact assessment 3 (PDF 172 KB)

Published:

21 October 2021
Committee member list (PDF 120 KB)

Published:

21 October 2021
Comments form (MSWord 40 KB)

Published:

21 October 2021
Draft guideline NG131 (PDF 421 KB)

Published:

21 October 2021
Draft guideline NG12 (PDF 209 KB)

Published:

21 October 2021
Stakeholder list updated
Stakeholder list (PDF 220 KB)

Published:

14 December 2021
Committee list updated
Committee member list (PDF 120 KB)

Published:

06 October 2021
Declaration of interests
Register of interests (PDF 398 KB)

Published:

14 December 2021
Scope published
Final scope (PDF 252 KB)

Published:

18 August 2021
Committee meeting
Minutes 1 (PDF 433 KB)

Published:

08 September 2021
Minutes 2 (PDF 182 KB)

Published:

15 September 2021
Minutes Post-consultation (PDF 180 KB)

Published:

15 November 2021

Original development on 09 May 2019

Declaration of interests
Register of interests (PDF 236 KB)

Published:

09 May 2019
Guidance published
Consultation comments and responses (PDF 1.14 MB)

Published:

09 May 2019
Equality impact assessment (PDF 106 KB)

Published:

09 May 2019
Committee member list (PDF 119 KB)

Published:

09 May 2019
Stakeholder list updated
Stakeholder list (PDF 247 KB)

Published:

09 May 2019
Equality and health inequalities assessment
Equality impact assessment 4 (PDF 106 KB)

Published:

12 April 2019
Draft guidance consultation
Draft guidance consultation
Stakeholder list (PDF 49 KB)

Published:

12 December 2018
Equality impact assessment (PDF 138 KB)

Published:

12 December 2018
Comments form (MSWord 33 KB)

Published:

12 December 2018
Evidence review A (PDF 2.09 MB)

Published:

12 December 2018
Evidence review B (PDF 1.7 MB)

Published:

12 December 2018
Evidence review C (PDF 1.83 MB)

Published:

12 December 2018
Evidence review D (PDF 3.58 MB)

Published:

12 December 2018
Evidence review E (PDF 5.1 MB)

Published:

12 December 2018
Evidence review G (PDF 5.66 MB)

Published:

12 December 2018
Evidence review H (PDF 1.37 MB)

Published:

12 December 2018
Economic report (PDF 11.36 MB)

Published:

12 December 2018
Guideline appendix Algorithm (PDF 275 KB)

Published:

12 December 2018
Guideline appendix Acknowledgements (PDF 236 KB)

Published:

12 December 2018
Guideline appendix Register of interests (PDF 424 KB)

Published:

12 December 2018
Committee member list (PDF 156 KB)

Published:

12 December 2018
Draft guideline (PDF 717 KB)

Published:

12 December 2018
Evidence review F (PDF 1.68 MB)

Published:

12 December 2018
Pre-consultation documents released
Search strategies (PDF 437 KB)

Published:

23 October 2018
Economic plan (PDF 123 KB)

Published:

23 October 2018
Review questions (PDF 197 KB)

Published:

23 October 2018
Committee list updated
Committee member list (PDF 158 KB)

Published:

07 August 2018
Scope published
Equality impact assessment 2 (PDF 233 KB)

Published:

20 October 2017
Final scope (PDF 453 KB)

Published:

20 October 2017
Consultation comments and responses (PDF 944 KB)

Published:

20 October 2017
Draft scope consultation
Draft scope consultation
Equality impact assessment (PDF 211 KB)

Published:

30 June 2017
Comments form (MSWord 66 KB)

Published:

30 June 2017
Draft scope (PDF 459 KB)

Published:

30 June 2017
Committee meeting
Minutes 1 (PDF 341 KB)

Published:

11 October 2017
Minutes 2 (PDF 322 KB)

Published:

28 November 2017
Minutes 3 (PDF 310 KB)

Published:

09 January 2018
Minutes 4 (PDF 247 KB)

Published:

20 February 2018
Minutes 5 (PDF 300 KB)

Published:

18 April 2018
Minutes 6 (PDF 181 KB)

Published:

22 May 2018
Minutes 7 (PDF 181 KB)

Published:

11 July 2018
Minutes 8 (PDF 185 KB)

Published:

12 September 2018
Minutes 9 (PDF 124 KB)

Published:

04 February 2019